Natalizumab antibodies (Tysabri antibodies)
Clinical Biochemistry
Sample and container requirements
Serum SST
Minimum volume required
500 μL serum
Special requirements
Store and send frozen.
Patient preparation
None
Sample viability
Turnaround time
21 days
Reference range
Please refer to report for reference ranges.
Clinical guidance
Please follow the link below to the referral laboratory website for more information: https://www.eselpathology.nhs.uk/immunology
Notes
Sent to Royal London Hospital
Images to go here
This information was last updated on 19 August 2026